Levamisole

Welcome to Dwaey, specifically on Levamisole page.
This medicine contains important and useful components, as it consists of
Levamisole is available in the market in concentration.

Generic Name of Levamisole - Learn More

Levamisole

Levamisole Precaution - What You Need to Know

Levamisole is an anti-parasitic drug primarily used in the treatment of helminthic infections and as an adjunct therapy for certain autoimmune conditions, though it is less commonly used today due to the availability of safer alternatives. When considering the use of levamisole, several precautions must be observed, particularly in certain patient populations. Patients with a history of bone marrow suppression or those undergoing immunosuppressive treatment should be closely monitored, as levamisole may induce leukopenia (reduced white blood cell count), which can make patients more susceptible to infections.

Levamisole should be used with caution in patients with liver or kidney impairments, as these conditions can affect the metabolism and clearance of the drug, leading to a higher risk of toxicity. Liver function tests and complete blood counts should be monitored regularly during therapy.

Pregnant women should avoid levamisole due to its potential teratogenic effects in animals. Its safety during pregnancy in humans has not been adequately studied, and it should only be prescribed if the benefits outweigh the potential risks. The drug is also contraindicated in breastfeeding, as it is not known whether levamisole passes into breast milk, but given its potential toxicity, it is safer to avoid its use while nursing.

Levamisole Indication - Uses and Benefits

Levamisole was originally approved as an anti-parasitic medication for treating conditions such as ascariasis (roundworm infections), hookworm, and other parasitic worm infections. It is also used in the management of certain autoimmune diseases, including as an adjunct therapy for rheumatoid arthritis. However, due to its immune-modulating properties, it is more commonly used as an adjunctive treatment for specific conditions rather than as a primary therapy.

In some cases, levamisole is used to treat conditions where the immune system is compromised or underactive, as it has been shown to stimulate certain immune responses, particularly in patients with chronic or recurrent infections. In addition to its primary uses, levamisole has been studied off-label for other conditions like certain types of cancers, though this is not a standard or widely approved use.

Though it is effective for its indications, levamisole’s usage has become limited due to its side-effect profile and the advent of newer, safer treatments for parasitic infections and autoimmune conditions.

Levamisole Contraindications - Important Warnings

Levamisole is contraindicated in patients who are hypersensitive to the drug or any of its components. Additionally, it should not be used in patients with active bone marrow disorders, including leukopenia, agranulocytosis, or any history of blood dyscrasias, as levamisole can cause further suppression of bone marrow and result in significant hematological side effects.

Patients with severe liver or kidney impairment should avoid levamisole unless the benefits significantly outweigh the risks, as these conditions may impair the metabolism or elimination of the drug, potentially leading to toxicity.

Levamisole is contraindicated in pregnancy due to its teratogenic effects seen in animal studies. It should also be avoided in breastfeeding women, as there is insufficient data on the safety of levamisole during lactation. Pediatric use is also limited, and levamisole should be used in children only when absolutely necessary and with careful monitoring.

Levamisole Side Effects - What to Expect

Levamisole is associated with a number of side effects, some of which can be severe. The most common side effects include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. These side effects are usually mild but may persist in some individuals.

A significant side effect of levamisole is its potential to cause hematological toxicity, most notably leukopenia, which can lead to an increased risk of infections. Other blood-related side effects include agranulocytosis (a severe reduction in white blood cells) and thrombocytopenia (low platelet count). Regular monitoring of blood counts is essential during treatment to detect these potentially serious side effects early.

Levamisole can also cause neurological effects, such as dizziness, headache, and confusion. Skin reactions, including rashes, may also occur, and in rare cases, more severe cutaneous reactions like erythema multiforme or vasculitis have been reported. Patients should be monitored for any signs of allergic reactions or severe skin conditions.

Long-term use of levamisole may increase the risk of severe autoimmune reactions, including lupus-like syndrome, which presents with symptoms such as joint pain, skin rashes, and fatigue.

Levamisole Pregnancy Category ID - Safety Information

3

Levamisole Mode of Action - How It Works

Levamisole works by stimulating the immune system, particularly through its effects on T-cell activity. It is a direct immunomodulator and works to enhance cellular immunity by promoting the activation of T-helper cells. Levamisole also increases the production of various cytokines, which are important in the immune response, and it enhances the phagocytic activity of macrophages, leading to improved defense against infections.

In addition to its immune-modulating effects, levamisole also has direct anthelmintic activity. It works by interfering with the nervous system of parasitic worms, leading to paralysis and the eventual expulsion of the worms from the host. This effect is achieved by inhibiting the metabolism of glucose in the parasites, which results in their immobilization.

Pharmacokinetically, levamisole is well absorbed after oral administration and is extensively metabolized by the liver. It has a relatively short half-life of 3–4 hours, which necessitates frequent dosing for optimal therapeutic effect.

Levamisole Drug Interactions - What to Avoid

Levamisole may interact with a number of medications, affecting their efficacy or increasing the risk of side effects. Key interactions include:

- Immunosuppressants: Levamisole can potentiate the effects of immunosuppressive drugs, leading to an increased risk of infections. Patients receiving levamisole with other immunosuppressive agents should be closely monitored for signs of infection or other immune-related issues.
- CYP450 enzyme inhibitors: Levamisole is metabolized by the liver, particularly via the cytochrome P450 enzyme system. Drugs that inhibit these enzymes (such as ketoconazole, itraconazole, and grapefruit juice) may increase the plasma concentration of levamisole, leading to a higher risk of toxicity, including hematological abnormalities.
- Warfarin: Levamisole can enhance the anticoagulant effects of warfarin, leading to an increased risk of bleeding. Monitoring of INR (international normalized ratio) is necessary when levamisole is used in combination with warfarin.

There are no significant food interactions with levamisole; however, alcohol consumption should be minimized, as it can contribute to liver toxicity, especially in patients with pre-existing liver issues. Levamisole is often used with other medications, so patients should inform their healthcare provider of all drugs they are taking, including over-the-counter products, to avoid potential interactions.

Levamisole Adult Dose - Recommended Dosage

For adults, the typical dosage of levamisole for the treatment of helminthic infections is 150 mg once daily for 3 consecutive days. The specific dose may vary based on the type of parasitic infection and the individual patient's response to treatment. For autoimmune conditions like rheumatoid arthritis, levamisole is often used in lower doses, typically 50-100 mg daily, as part of a combination therapy regimen.

In cases where levamisole is used for longer-term management, close monitoring for hematological side effects and liver function is necessary. The drug should not be used indefinitely without regular blood count monitoring, especially in patients with pre-existing bone marrow conditions.

Levamisole Child Dose - Dosage for Children

Levamisole is not routinely prescribed for children, as the safety and efficacy of the drug in pediatric populations have not been well established. In pediatric cases where it may be considered (such as for treating parasitic infections), the dosage would generally be determined based on the child’s weight and specific condition. Pediatric dosing is typically lower than that of adults, and careful monitoring for side effects is essential, particularly concerning hematological parameters.

Given the potential for significant side effects, especially related to bone marrow suppression, levamisole should only be used in children under strict medical supervision and when absolutely necessary.

Levamisole Renal Dose - Dosage for Kidney Conditions

Levamisole is primarily metabolized by the liver, and its renal clearance is not significant. However, in patients with severe renal impairment (creatinine clearance less than 30 mL/min), levamisole should be used with caution, and the potential for increased drug toxicity should be considered. In such patients, the drug may accumulate, and careful monitoring of renal function and blood counts is required.

If renal function declines during treatment, dose adjustment may be necessary to avoid potential toxicity.